Global Plant Genomics Market to Reach $18.6 Billion by 2030
The global market for Plant Genomics estimated at US$7.8 Billion in the year 2022, is projected to reach a revised size of US$18.6 Billion by 2030, growing at a CAGR of 11.6% over the analysis period 2022-2030. Molecular Engineering, one of the segments analyzed in the report, is projected to record 12.2% CAGR and reach US$9.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Genetic Engineering segment is readjusted to a revised 11.2% CAGR for the next 8-year period.The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 11% CAGR
The Plant Genomics market in the U.S. is estimated at US$2.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.8% and 9.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.Select Competitors (Total 33 Featured) -
- Agilent Technologies
- BGI Genomics
- Eurofins Scientific
- Floragenex
- Genewiz
- Genotypic Technologies
- Illumina, Inc.
- KeyGene
- LC Sciences
- Neogen Corporation
- Novogene Corporation
- NRGene
- Oxford Nanopore Technologies
- Qiagen
- Traitgenetics GmbH
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies
- BGI Genomics
- Eurofins Scientific
- Floragenex
- Genewiz
- Genotypic Technologies
- Illumina, Inc.
- KeyGene
- LC Sciences
- Neogen Corporation
- Novogene Corporation
- NRGene
- Oxford Nanopore Technologies
- Qiagen
- Traitgenetics GmbH
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 7.8 Billion |
Forecasted Market Value ( USD | $ 18.6 Billion |
Compound Annual Growth Rate | 11.5% |
Regions Covered | Global |